Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Kalypsys logo — Shaping the future of medicine through comprehensive, automa...

Kalypsys

Shaping the future of medicine through comprehensive, automated drug discovery and development services across multiple therapeutic areas.

Founded 2001 Series C Total: $171.00M Biotechnology, Health and Wellness

General Information

Company Name Kalypsys
Founded Year 2001
Industries Biotechnology, Health and Wellness
Funding Stage Series C
Social

Get notified when Kalypsys moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Kalypsys

Kalypsys is a biotechnology company founded in 2001 that is focused on shaping the future of medicine through comprehensive, automated drug discovery and development services across multiple therapeutic areas. The company's slogan reflects its commitment to leveraging pathway-based drug discovery and development services. Kalypsys works with an integrated suite of technologies in biology, chemistry, and informatics to advance discovery programs across a broad spectrum of therapeutic areas. The latest significant investment in the company was a $100.00M Series C investment on 29 November 2006, with notable investors including CMEA Capital, KT Venture Group, Sprout Group, and Tavistock Life Sciences.

Taxonomy: drug discovery, drug development, therapeutic areas, automated technologies, pathway-based, biology, chemistry, informatics, integrated technologies, comprehensive services

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Series C •••••• 4
Investor Investor Investor Investor
29 Nov 2006
Series B •••••• 6
Investor Investor Investor Investor Investor
•••• •••• 		05 Aug 2004
Series A •••••• - 03 May 2002

Kalypsys Alternatives & Competitors

Kalypsys vs
Synfini, Inc.
Synfini, Inc. United States

The Agile Drug Discovery Company

Unknown
14 employees
AI, Pharmaceutical
Kalypsys vs
xilis
xilis United States

Next generation technologies for precision medicine.

Series A
74 employees
Biotechnology, Health Care
Kalypsys vs
TissueX Technologies
TissueX Technologies

Boosting drug discovery efficiency with enhanced cell-based assay predictability and quantification...

Seed
Biotechnology, Pharmaceutical
Also compare with: Kalypsys vs Novalix Novalix

FAQ About Kalypsys

Shaping the future of medicine through comprehensive, automated drug discovery and development services across multiple therapeutic areas.
Kalypsys was founded in 2001.
Kalypsys operates in the following industries: Biotechnology, Health and Wellness.
Kalypsys has completed 3 funding rounds, raising a total of $171.00M. The latest funding stage is Series C.
Top alternatives and competitors to Kalypsys include Synfini, Inc., xilis, TissueX Technologies, SpiroChem, AIGEN Sciences Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Kalypsys and Synfini, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Kalypsys and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy